RAC1 and colorectal carcinoma: Currently, EMT is not directly targeted by specific treatments in CRC, but given the roles of RAC1 and RAC1B in EMT described above, RAC1 and RAC1B could provide an option for combination therapies since EMT is associated with treatment resistance.